Autor/in Nashan, Björn Vincenti, F Bumgardner, G L 1 Ekberg, H 1 Grinyó, J 1 Hardie, I 1 Johnson, R W 1 Lin, A 1 Nasmyth-Miller, C 1 Pescovitz, M D 1 Ramos, E 1 Rashford, M 1 Truman, M 1 Vanrenterghem, Y 1 Voulgari, A 1 alle zeigenListe einklappen
Cyclosporine sparing with mycophenolate mofetil, daclizumab and corticosteroids in renal allograft recipients: the CAESAR Study. Ekberg, H Grinyó, J Nashan, Björn Vanrenterghem, Y Vincenti, F Voulgari, A Truman, M 2007 - Forschungsinformationssystem des UKE
Results of 3-year phase III clinical trials with daclizumab prophylaxis for prevention of acute rejection after renal transplantation. Bumgardner, G L Hardie, I Johnson, R W Lin, A Nashan, Björn Pescovitz, M D Ramos, E 2001 - Forschungsinformationssystem des UKE
